When their function is impaired in APS, normal blood clotting can be affected. Because of this, people with APS may face pregnancy complications that require close monitoring and treatment.
Overview
When APS antibodies prevent proteins in the blood from binding to phospholipids, the normal balance between bleeding and clotting is upset. This can result in the blockage of blood flow and the formation of blood clots, which can lead to deep vein thrombosis, strokes, and heart attacks if left untreated. Like many other autoimmune conditions, the cause of APS is unknown. Medical experts believe that genetics and infections may both play a role. Smoking also appears to raise the risk of developing APS. This condition can be diagnosed as a stand-alone disease (called primary APS), or it may occur along with another autoimmune disease (such as lupus). In this case it is called secondary APS.
Incidence
Antiphospholipid (APL) antibodies are present in about 1% to 5% of healthy people and 20% to 40% of those with lupus. An estimated 75% to 90% of APS patients are women.
Relationship to Recurrent Miscarriages
APS accounts for approximately 15% of recurrent miscarriages, with half of those losses occurring in the first trimester. While the reason for APS-associated miscarriages is unclear, some researchers believe that the blood clots seen in APS can block the blood supply to the placenta. APS is a well-established cause of later miscarriages, but doctors are still unsure of the role that aPL antibodies might play in early miscarriage. Other pregnancy complications that are linked to APS include:
Neonatal complications Oligohydramnios Placental insufficiency Pre-eclampsia Pre-term delivery
Symptoms
Most people who have aPL antibodies have no symptoms. For women, recurrent miscarriages may be the only symptom. In rare cases, patients may develop catastrophic anti-phospholipid syndrome (CAPS), in which major blood clots form over a period of days, resulting in acute blockage of vessels that requires immediate medical attention.
Diagnosis
APS testing is not a routine screening during pregnancy; rather, it is only done in people who have had unexpected blood clots or recurrent miscarriages.
Pain, numbness, or unusually pale skin in an arm or legShortness of breathSwelling or redness in a leg
Generally, when considering APS as a possible factor in recurrent miscarriages, doctors look for a person to be positive for lupus anticoagulant or aPL on more than one occasion before making a diagnosis.
Blood clotting tests to check for lupus anticoagulantAntiphospholipid antibody (aPL) tests, which can include anticardiolipid antibody and/or antibodies to beta-2 glycoprotein 1
Either a positive blood clotting test or a positive aPL test can result in an APS diagnosis, but only if the person also has symptoms such as blood clots and/or repeated miscarriages. Diagnosing APS can be a challenge because the standard tests for lupus anticoagulant antibodies are somewhat unreliable. In addition, sensitivity can vary based on the agent used in each laboratory.
Treatment and Prognosis
Women who have been diagnosed with APS have about a 70% chance of a successful pregnancy with treatment, which usually consists of low-dose aspirin and/or heparin injections. While this treatment improves pregnancy outcomes, it can increase the rates of third-trimester pregnancy complications. Because of this, people with APS are usually seen by a high-risk OB/GYN during pregnancy for monitoring and treatment. Those who have a second autoimmune disease will need to be followed by their rheumatologist as well. Some OB/GYNs advise against the use of hormonal contraception in women with APS because of the added risk of blood clots. A long-acting intrauterine device (IUD) is often recommended instead. With long-term treatment for APS, recurrent blood clots can be avoided and patients can look forward to a long and healthy life.
